{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:51:08Z","timestamp":1790175068848,"version":"4.1.0"},"reference-count":76,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2001,6,1]],"date-time":"2001-06-01T00:00:00Z","timestamp":991353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Haematology"],"published-print":{"date-parts":[[2001,6]]},"DOI":"10.1053\/beha.2001.0134","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T11:24:48Z","timestamp":1027682688000},"page":"281-298","source":"Crossref","is-referenced-by-count":34,"title":["A molecular approach to the classification of von Willebrand disease"],"prefix":"10.1053","volume":"14","author":[{"given":"Reinhard","family":"Schneppenheim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrich","family":"Budde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaverio M.","family":"Ruggeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/beha.2001.0134_RF1","first-page":"7","article-title":"Heredit\u00e4r pseudohemofili","volume":"672","author":"von Willebrand","year":"1926","journal-title":"Finska L\u00e4kares\u00e4llskaptes Handlingar"},{"key":"10.1053\/beha.2001.0134_RF2","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1172\/JCI106480","volume":"50","author":"Zimmerman","year":"1971","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beha.2001.0134_RF3","first-page":"453","article-title":"\u00dcber ein neues vererbbares Blutungs\u00fcbel: die konstitutionelle Thrombopathie","volume":"175","author":"von Willebrand","year":"1933","journal-title":"Deutsches Archiv f\u00fcr Klinische Medizin"},{"key":"10.1053\/beha.2001.0134_RF4","first-page":"347","article-title":"Vascular hemophilia. A familial hemorraghic disease in males and females characterized by combined antihemophilic globulin deficiency and vascular abnormalities","volume":"18","author":"Shulman","year":"1956","journal-title":"Pediatrics"},{"key":"10.1053\/beha.2001.0134_RF5","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1136\/bmj.3.5822.317","article-title":"Genetic variants of von Willebrand\u2019s disease","volume":"3","author":"Holmberg","year":"1972","journal-title":"British Medical Journal"},{"key":"10.1053\/beha.2001.0134_RF6","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1182\/blood.V70.4.895.895","article-title":"von Willebrand factor and von Willebrand disease","volume":"70","author":"Ruggeri","year":"1987","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0134_RF7","series-title":"Thrombosis and Haemostasis","first-page":"419","article-title":"Classifcation of von Willebrand disease","author":"Ruggeri","year":"1987"},{"key":"10.1053\/beha.2001.0134_RF8","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1126\/science.3874428","article-title":"Human von Willebrand factor (VWF): isolation of complementary DNA (cDNA) clones and chromosomal localization","volume":"228","author":"Ginsburg","year":"1985","journal-title":"Science"},{"key":"10.1053\/beha.2001.0134_RF9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0092-8674(85)90060-1","article-title":"Molecular cloning of cDNA for human von Willebrand factor: authentication by a new method","volume":"41","author":"Lynch","year":"1985","journal-title":"Cell"},{"key":"10.1053\/beha.2001.0134_RF10","doi-asserted-by":"crossref","first-page":"6394","DOI":"10.1073\/pnas.82.19.6394","article-title":"Cloning and characterization of two cDNAs coding for human von Willebrand factor","volume":"82","author":"Sadler","year":"1985","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beha.2001.0134_RF11","doi-asserted-by":"crossref","first-page":"4699","DOI":"10.1093\/nar\/13.13.4699","article-title":"Construction of cDNA coding for human von Willebrand factor using antibody probes for colony-screening and mapping of the chromosomal gene","volume":"13","author":"Verweij","year":"1985","journal-title":"Nucleic Acids Research"},{"key":"10.1053\/beha.2001.0134_RF12","doi-asserted-by":"crossref","first-page":"19514","DOI":"10.1016\/S0021-9258(19)47144-5","article-title":"Structure of the gene for human von Willebrand factor","volume":"264","author":"Mancuso","year":"1989","journal-title":"Journal of Biological Chemistry"},{"key":"10.1053\/beha.2001.0134_RF13","first-page":"18","article-title":"Enzyme-linked immunoabsorbent assay of factor VIII-related antigen. Interest in study of von Willebrand\u2019s disease","volume":"25","author":"Mazurier","year":"1977","journal-title":"Pathology and Biology (Paris)"},{"key":"10.1053\/beha.2001.0134_RF14","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1172\/JCI107465","article-title":"Quantitative assay of a plasma factor deficient in von Willebrand\u2019s disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content","volume":"52","author":"Weiss","year":"1973","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beha.2001.0134_RF15","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1172\/JCI109795","article-title":"Variant von Willebrand\u2019s disease: characterization of two subtypes by analysis of multimeric composition of factor VIII\/von Willebrand factor in plasma and platelets","volume":"65","author":"Ruggeri","year":"1980","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beha.2001.0134_RF16","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1056\/NEJM198005083021902","article-title":"Heightened interaction between platelets and factor VIII\/von Willebrand factor in new subtype of von Willebrand\u2019s disease","volume":"302","author":"Ruggeri","year":"1980","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2001.0134_RF17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0049-3848(86)90150-7","article-title":"An ELISA test for the binding of von Willebrand antigen to collagen","volume":"43","author":"Brown","year":"1986","journal-title":"Thrombosis Research"},{"key":"10.1053\/beha.2001.0134_RF18","first-page":"598","article-title":"Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1","volume":"764","author":"Schneppenheim","year":"1996","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0134_RF19","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1182\/blood.V57.6.1140.1140","article-title":"The complex multimeric composition of factor VIII\/von Willebrand factor","volume":"57","author":"Ruggeri","year":"1981","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0134_RF20","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/0049-3848(85)90263-4","article-title":"A modified SDS agarose gel method for determining factor VIII von Willebrand factor multimers using commercially available reagents","volume":"39","author":"Miller","year":"1985","journal-title":"Thrombosis Research"},{"key":"10.1053\/beha.2001.0134_RF21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-0038-1647016","article-title":"Luminography\u2014an alternative assay for detection of von Willebrand factor multimers","volume":"60","author":"Schneppenheim","year":"1988","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0134_RF22","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1055\/s-0038-1642471","article-title":"A revised classification of von Willebrand disease","volume":"71","author":"Sadler","year":"1994","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0134_RF23","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1172\/JCI112974","article-title":"Gene deletions correlate with the development of alloantibodies in von Willebrand disease","volume":"79","author":"Shelton-Inloes","year":"1987","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beha.2001.0134_RF24","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.1073\/pnas.85.8.2753","article-title":"Homozygous and heterozygous deletions of the von Willebrand factor gene in patients and carriers of severe von Willebrand disease","volume":"85","author":"Ngo","year":"1988","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beha.2001.0134_RF25","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1182\/blood.V78.4.1148.1148","article-title":"A stop codon in a patient with severe type III von Willebrand disease","volume":"78","author":"Bahnak","year":"1991","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0134_RF26","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1055\/s-0038-1646295","article-title":"Mutations in severe, type III von Willebrand\u2019s disease in the Dutch population: candidate missense and nonsense mutations associated with reduced levels of von Willebrand factor messenger RNA","volume":"68","author":"Eikenboom","year":"1992","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0134_RF27","first-page":"850","article-title":"Nonsense mutations of the von Willebrand factor gene in patients with von Willebrand disease type III and type I","volume":"51","author":"Zhang","year":"1992","journal-title":"American Journal of Human Genetics"},{"key":"10.1053\/beha.2001.0134_RF28","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1006\/geno.1994.1241","article-title":"Characterization of the von Willebrand factor gene (VWF) in von Willebrand disease type III patients from 24 families of Swedish and Finnish origin","volume":"211","author":"Zhang","year":"1994","journal-title":"Genomics"},{"key":"10.1053\/beha.2001.0134_RF29","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1007\/BF00206958","article-title":"Genetic heterogeneity of severe von Willebrand disease type III in the German population","volume":"94","author":"Schneppenheim","year":"1994","journal-title":"Human Genetics"},{"key":"10.1053\/beha.2001.0134_RF30","unstructured":"Ginsburg, D, Sadler, J, E, von Willebrand Factor (VWF) Database, f1http:\/\/mmg2immedumichedu\/vWF\/f1"},{"key":"10.1053\/beha.2001.0134_RF31","first-page":"709","article-title":"Characterization of the genetic defects in recessive type 1 and type 3 von Willebrand disease patients of Italian origin","volume":"794","author":"Eikenboom","year":"1998","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0134_RF32","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1182\/blood.V96.2.560","article-title":"A novel von Willebrand disease-causing mutation (Arg273Trp) in the von Willebrand factor propeptide that results in defective multimerization and secretion","volume":"962","author":"Allen","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0134_RF33","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1182\/blood.V97.7.2059","article-title":"Expression and characterization of von Willebrand factor dimerization defects in different types of von Willebrand disease","volume":"97","author":"Schneppenheim","year":"2001","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0134_RF34","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1182\/blood.V66.4.796.796","article-title":"Heterogeneity of type I von Willebrand disease: evidence for a subgroup with an abnormal von Willebrand factor","volume":"664","author":"Mannucci","year":"1985","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0134_RF35","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/j.1365-2141.1983.tb02165.x","article-title":"von Willebrand factor multimer patterns in von Willebrand\u2019s disease","volume":"55","author":"Hoyer","year":"1983","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2001.0134_RF36","first-page":"411","article-title":"Heterogeneous abnormalities in the multimeric structure, antigenic properties, and plasma-platelet content of factor VIII\/von Willebrand factor in subtypes of classic (type I) and variant (type IIA) von Willebrand\u2019s disease","volume":"1013","author":"Weiss","year":"1983","journal-title":"Journal of Laboratory and Clinical Medicine"},{"key":"10.1053\/beha.2001.0134_RF37","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1172\/JCI110700","article-title":"Aberrant multimeric structure of von Willebrand factor in a new variant of von Willebrand\u2019s disease (type IIC)","volume":"70","author":"Ruggeri","year":"1982","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beha.2001.0134_RF38","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1182\/blood.V63.6.1369.1369","article-title":"A new variant of dominant type II von Willebrand\u2019s disease with aberrant multimeric pattern of factor VIII-related antigen (type IID)","volume":"63","author":"Kinoshita","year":"1984","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0134_RF39","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1136\/jcp.38.6.665","article-title":"Investigation of a kindred with a new autosomal dominantly inherited variant type von Willebrand\u2019s disease (possible type IID)","volume":"38","author":"Hill","year":"1985","journal-title":"Journal of Clinical Pathology"},{"key":"10.1053\/beha.2001.0134_RF40","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1172\/JCI112394","article-title":"Subunit composition of plasma von Willebrand factor. Cleavage is present in normal individuals, increased in IIA and IIB von Willebrand disease, but minimal in variants with aberrant structure of individual oligomers (types IIC, IID, and IIE)","volume":"77","author":"Zimmerman","year":"1986","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beha.2001.0134_RF41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1182\/blood.V68.1.269.269","article-title":"A new variant of type II von Willebrand disease with aberrant multimeric structure of plasma but not platelet von Willebrand factor (type IIF)","volume":"68","author":"Mannucci","year":"1986","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0134_RF42","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/ajh.2830240305","article-title":"A variant of type II von Willebrand disease with an abnormal triplet structure and discordant effects of protease inhibitors on plasma and platelet von Willebrand factor structure","volume":"243","author":"Gralnick","year":"1987","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0134_RF43","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ajh.2830320409","article-title":"Type II H von Willebrand disease: new structural abnormality of plasma and platelet von Willebrand factor in a patient with prolonged bleeding time and borderline levels of ristocetin cofactor activity","volume":"324","author":"Federici","year":"1989","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0134_RF44","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0049-3848(92)90165-7","article-title":"A new variant of von Willebrand disease (type II I) with a normal degree of proteolytic cleavage of von Willebrand factor","volume":"653","author":"Castaman","year":"1992","journal-title":"Thrombosis Research"},{"key":"10.1053\/beha.2001.0134_RF45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1182\/blood.V68.1.149.149","article-title":"A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers","volume":"68","author":"Weiss","year":"1986","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0134_RF46","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1182\/blood.V68.3.668.668","article-title":"von Willebrand\u2019s disease characterized by increased ristocetin sensitivity and the presence of all von Willebrand factor multimers in plasma","volume":"68","author":"Holmberg","year":"1986","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0134_RF47","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1445-5994.1973.tb03086.x","article-title":"von Willebrand\u2019s disease type B: a newly defined bleeding diathesis","volume":"33","author":"Firkin","year":"1973","journal-title":"Australian and New Zealand Journal of Medicine"},{"key":"10.1053\/beha.2001.0134_RF48","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1182\/blood.V71.1.65.65","article-title":"von Willebrand disease \u2018Vicenza\u2019 with larger-than-normal (supranormal) von Willebrand factor multimers","volume":"71","author":"Mannucci","year":"1988","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0134_RF49","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1182\/blood.V66.6.1423.1423","article-title":"High-resolution analysis of von Willebrand factor multimeric composition defines a new variant of type I von Willebrand disease with aberrant structure but presence of all size multimers (type IC)","volume":"666","author":"Ciavarella","year":"1985","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0134_RF50","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/ajh.2830360302","article-title":"Abnormal proteolytic degradation of von Willebrand factor after desmopressin infusion in a new subtype of von Willebrand disease (ID)","volume":"363","author":"Lopez-Fernandez","year":"1991","journal-title":"American Journal of Hematology"},{"key":"10.1053\/beha.2001.0134_RF51","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1182\/blood.V74.5.1591.1591","article-title":"New variant of von Willebrand disease with defective binding to factor VIII","volume":"74","author":"Nishino","year":"1989","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0134_RF52","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1182\/blood.V75.1.20.20","article-title":"A new von Willebrand factor (vWF) defect in a patient with factor VIII (FVIII) deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF\/FVIII interaction","volume":"75","author":"Mazurier","year":"1990","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0134_RF53","first-page":"203","article-title":"Von Willebrand\u2019s disease","volume":"6","author":"Zimmerman","year":"1982","journal-title":"Progress in Hemostasis and Thrombosis"},{"key":"10.1053\/beha.2001.0134_RF54","doi-asserted-by":"crossref","first-page":"4424","DOI":"10.1016\/S0021-9258(18)42852-9","article-title":"Impaired intracellular transport produced by a subset of type IIA von Willebrand disease mutations","volume":"267","author":"Lyons","year":"1992","journal-title":"Journal of Biological Chemistry"},{"key":"10.1053\/beha.2001.0134_RF55","doi-asserted-by":"crossref","first-page":"6306","DOI":"10.1073\/pnas.87.16.6306","article-title":"Identification of a cleavage site directing the immunochemical detection of molecular abnormalities in type IIA von Willebrand factor","volume":"87","author":"Dent","year":"1990","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beha.2001.0134_RF56","doi-asserted-by":"crossref","first-page":"3723","DOI":"10.1073\/pnas.86.10.3723","article-title":"Molecular basis of human von Willebrand disease: analysis of platelet von Willebrand factor mRNA","volume":"86","author":"Ginsburg","year":"1989","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beha.2001.0134_RF57","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1073\/pnas.93.8.3581","article-title":"Defective dimerization of von Willebrand factor subunits due to a Cys Arg mutation in type IID von Willebrand disease","volume":"938","author":"Schneppenheim","year":"1996","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beha.2001.0134_RF58","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1182\/blood.V84.4.1024.1024","article-title":"Characterization of von Willebrand factor gene defects in two unrelated patients with type IIC von Willebrand disease","volume":"844","author":"Gaucher","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0134_RF59","first-page":"681","article-title":"Identification of a candidate missense mutation in a family with von Willebrand disease type IIC","volume":"956","author":"Schneppenheim","year":"1995","journal-title":"Human Genetics"},{"key":"10.1053\/beha.2001.0134_RF60","first-page":"718","article-title":"Ins405AsnPro mutation in the von Willebrand factor propeptide in recessive type 2A (IIC) von Willebrand\u2019s disease","volume":"794","author":"Holmberg","year":"1998","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0134_RF61","article-title":"von Willebrand disease type 2A with aberrant structure of individual oligomers is caused by mutations clustering in the von Willebrand factor D3 domain","volume":"Supplement","author":"Schneppenheim","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0134_RF62","article-title":"The first mutations in von Willebrand disease type IIC Miami","author":"Schneppenheim","year":"2001","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0134_RF63","doi-asserted-by":"crossref","first-page":"2946","DOI":"10.1073\/pnas.88.7.2946","article-title":"Identification of a point mutation in type IIB von Willebrand disease illustrating the regulation of von Willebrand factor affinity for the platelet membrane glycoprotein Ib\u2013IX receptor","volume":"887","author":"Ware","year":"1991","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beha.2001.0134_RF64","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1172\/JCI115123","article-title":"The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domain","volume":"874","author":"Cooney","year":"1991","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beha.2001.0134_RF65","doi-asserted-by":"crossref","unstructured":"Randi, A, M, Rabinowitz, I, Mancuso, D, J, Molecular basis of von Willebrand disease type IIB. Candidate mutations cluster in one disulfide loop between proposed platelet glycoprotein Ib binding sequences, Journal of Clinical Investigation, 874, 1220, 1226","DOI":"10.1172\/JCI115122"},{"key":"10.1053\/beha.2001.0134_RF66","first-page":"451","article-title":"Gene defects in 150 unrelated French cases with type 2 von Willebrand disease: from the patient to the gene. INSERM network on molecular abnormalities in von Willebrand disease","volume":"781","author":"Meyer","year":"1997","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0134_RF67","first-page":"136","article-title":"von Willebrand Disease type 2M \u2018Vicenza\u2019 in Italian and German patients: identification of the first candidate mutation (G3864A; R1205H) in 8 families","volume":"831","author":"Schneppenheim","year":"2000","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0134_RF68","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1055\/s-0037-1614162","article-title":"Identification of type 2 von Willebrand disease in previously diagnosed type 1 patients: a reappraisal using phenotypes, genotypes and molecular modelling","volume":"84","author":"Nitu-Whalley","year":"2000","journal-title":"Thrombosis and Haemostasis"},{"key":"10.1053\/beha.2001.0134_RF69","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1182\/blood.V77.9.1937.1937","article-title":"The \u2019Normandy\u2018 variant of von Willebrand disease: characterization of a point mutation in the von Willebrand factor gene","volume":"77","author":"Gaucher","year":"1991","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0134_RF70","doi-asserted-by":"crossref","first-page":"19146","DOI":"10.1016\/S0021-9258(18)54972-3","article-title":"Abnormal binding of factor VIII is linked with the substitution of glutamine for arginine 91 in von Willebrand factor in a variant form of von Willebrand disease","volume":"266","author":"Kroner","year":"1991","journal-title":"Journal of Biological Chemistry"},{"key":"10.1053\/beha.2001.0134_RF71","doi-asserted-by":"crossref","first-page":"13499","DOI":"10.1016\/S0021-9258(18)92725-0","article-title":"Molecular characterization of a unique von Willebrand disease variant. A novel mutation affecting von Willebrand factor\/factor VIII interaction","volume":"266","author":"Cacheris","year":"1991","journal-title":"Journal of Biological Chemistry"},{"key":"10.1053\/beha.2001.0134_RF72","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1182\/blood.V92.12.4663","article-title":"A novel mutation in the D3 domain of von Willebrand factor markedly decreases its ability to bind factor VIII and affects its multimerization","volume":"9212","author":"Jorieux","year":"1998","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0134_RF73","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1182\/blood.V95.10.3139","article-title":"Conformational changes in the D\u2032 domain of von Willebrand factor induced by CYS 25 and CYS 95 mutations lead to factor VIII binding defect and multimeric impairment","volume":"9510","author":"Jorieux","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0134_RF74","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1182\/blood.V95.6.2000","article-title":"Two novel type 2N von Willebrand disease-causing mutations that result in defective factor VIII binding, multimerization, and secretion of von Willebrand factor","volume":"956","author":"Allen","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0134_RF75","article-title":"Characterization of a combined defect of FVIII binding and multimerization in a patient with von Willebrand disease type 2N","volume":"Supplement","author":"Schneppenheim","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2001.0134_RF76","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1182\/blood.V82.1.169.bloodjournal821169","article-title":"New variant of von Willebrand disease type II with markedly increased levels of von Willebrand factor antigen and dominant mode of inheritance: von Willebrand disease type IIC Miami","volume":"821","author":"Ledford","year":"1993","journal-title":"Blood"}],"container-title":["Best Practice & Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692601901343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692601901343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T06:27:26Z","timestamp":1621146446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692601901343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,6]]},"references-count":76,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2001,6]]}},"alternative-id":["S1521692601901343"],"URL":"https:\/\/doi.org\/10.1053\/beha.2001.0134","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2001,6]]}}}